FTV Capital provided the Restaurant Group-backed payment platform developer with fresh capital that will be used to boost its expansion across new industries.

FTX and Binance came on board for the game monetisation software developer’s series C round, taking its total funding to $270m.

SoftBank led the companionship service provider's latest round, pushing its total funding to $240m.

Tencent, Charles River Laboratories and National Resilience all backed the stem cell technology developer’s series B round.

Ubicom Holdings Japan helped gynaecological imaging software developer Illumigyn take its total funding to $33m while Optum took part in a $30m round for health payment technology provider Medallion.

The business management software developer hiked its overall funding to $465m and its valuation to $2.4bn in a Citi Ventures-backed round.

The wearable glucose monitor developer’s nine-figure series B round included M Ventures, Hikma Ventures, Axa Investment Management, Ascencia, Hikm Taisho, Cirrus Logic and EOFlow.

Alphabet returned to reinvest in the epigenetics diagnostics technology developer through a series D round that took its total funding to about $145m.

The hospitality software developer pushed its overall funding past $250m in a series D round led by SoftBank Vision Fund 2.

Bristol Myers Squibb was among the participants in cellular therapy developer Clade Therapeutics' series A round, with the proceeds to go to platform development.